Parameter | Median | Range | Description and reference |
---|---|---|---|
Costs | |||
Cost of capecitabine per 500 mg | 6.6 | Fixed | Local charge |
Cost of S-1 per 20 mg | 9.6 | 7.9 - 10.1 | Local charge |
Cost of oxaliplatin per 50 mg | 88.9 | 77.3 - 464.5 | Local charge |
Cost of follow-up per unit | 56.5 | 42.3 - 70.6 | Calculation |
Cost of tests per 6-weeks of adjuvant with S-1 | 197.8 | 15.9 - 317.5 | [31] |
Cost of salvage chemotherapy per 3-week cycle | 2334.6 | 1429.3 - 3323.2 | Calculation |
Cost of palliative end-of-life care | 1460.3 | 1055.3 - 2085.7 | Calculation |
Cost of supportive care per cycle | 115.2 | 31.7 - 317.5 | Calculation |
Cost of ADR per 6-week period of adjuvant with S-1 | 42.3 | 7.9 - 79.4 | [31] |
Cost of ADR per 3-week cycle of adjuvant with XELOX strategy | 68.9 | 15.9 - 158.7 | [31] |
Cost of hospitalization per 3-week cycle of adjuvant with XELOX strategy | 373 | 238.1 - 793.7 | [31] |
Utilities | |||
Utility of disease-free survival | 0.88 | 0.8 - 0.97 | Measured |
Utility of recurrent disease | 0.42 | 0.28 - 0.63 | Measured |